BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29920228)

  • 1. Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma.
    Molina L; Bell D; Tao J; Preziosi M; Pradhan-Sundd T; Singh S; Poddar M; Luo J; Ranganathan S; Chikina M; Monga SP
    Am J Pathol; 2018 Aug; 188(8):1895-1909. PubMed ID: 29920228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte-Like Cells.
    Smith JL; Rodríguez TC; Mou H; Kwan SY; Pratt H; Zhang XO; Cao Y; Liang S; Ozata DM; Yu T; Yin Q; Hazeltine M; Weng Z; Sontheimer EJ; Xue W
    Hepatology; 2021 Mar; 73(3):1011-1027. PubMed ID: 32452550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
    Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
    Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.
    Min Q; Molina L; Li J; Adebayo Michael AO; Russell JO; Preziosi ME; Singh S; Poddar M; Matz-Soja M; Ranganathan S; Bell AW; Gebhardt R; Gaunitz F; Yu J; Tao J; Monga SP
    Am J Pathol; 2019 May; 189(5):1091-1104. PubMed ID: 30794807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.
    Molina L; Yang H; Adebayo Michael AO; Oertel M; Bell A; Singh S; Chen X; Tao J; Monga SPS
    Oncotarget; 2019 Feb; 10(15):1475-1490. PubMed ID: 30863496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
    Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV
    J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
    Borkham-Kamphorst E; Drews F; Weiskirchen R
    Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice Through Endoplasmic Reticulum Stress and Unfolded Protein Response.
    Borkham-Kamphorst E; Haas U; Van de Leur E; Trevanich A; Weiskirchen R
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics characterization of mouse hepatoblastoma identifies yes-associated protein 1 target genes.
    Rodríguez TC; Kwan SY; Smith JL; Dadafarin S; Wu CH; Sontheimer EJ; Xue W
    Hepatology; 2023 Jul; 78(1):58-71. PubMed ID: 35932276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK9 is dispensable for YAP-driven hepatoblastoma development.
    Chen X; Kiss A; Schaff Z; Evert K; Zhang Y; Zhong S; Wang J; Evert M; Calvisi DF; Chen X
    Pediatr Blood Cancer; 2020 May; 67(5):e28221. PubMed ID: 32124532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver parenchymal cells lacking Lipocalin 2 (LCN2) are prone to endoplasmic reticulum stress and unfolded protein response.
    Borkham-Kamphorst E; Van de Leur E; Haas U; Weiskirchen R
    Cell Signal; 2019 Mar; 55():90-99. PubMed ID: 30615971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
    Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
    Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps.
    Li H; Feng D; Cai Y; Liu Y; Xu M; Xiang X; Zhou Z; Xia Q; Kaplan MJ; Kong X; Gao B
    Hepatology; 2018 Oct; 68(4):1604-1620. PubMed ID: 29633303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model.
    Armengol C; Cairo S; Fabre M; Buendia MA
    Int J Biochem Cell Biol; 2011 Feb; 43(2):265-70. PubMed ID: 19646548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipocalin-2 in liver regeneration.
    Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H
    Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.
    Borkham-Kamphorst E; van de Leur E; Zimmermann HW; Karlmark KR; Tihaa L; Haas U; Tacke F; Berger T; Mak TW; Weiskirchen R
    Biochim Biophys Acta; 2013 May; 1832(5):660-73. PubMed ID: 23376114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver regeneration requires Yap1-TGFβ-dependent epithelial-mesenchymal transition in hepatocytes.
    Oh SH; Swiderska-Syn M; Jewell ML; Premont RT; Diehl AM
    J Hepatol; 2018 Aug; 69(2):359-367. PubMed ID: 29758331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
    Karlsen JR; Borregaard N; Cowland JB
    J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans.
    Zhang S; Zhang J; Evert K; Li X; Liu P; Kiss A; Schaff Z; Ament C; Zhang Y; Serra M; Evert M; Chen N; Xu F; Chen X; Tao J; Calvisi DF; Cigliano A
    Am J Pathol; 2020 Jul; 190(7):1397-1413. PubMed ID: 32283103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.